Tofajak Ointment is a topical JAK inhibitor formulated with Tofacitinib (2% w/w) to treat inflammatory skin conditions such as vitiligo, atopic dermatitis, and psoriasis. It works by targeting the Janus kinase (JAK) pathway to reduce immune-mediated inflammation and support skin repigmentation and repair. Suitable for long-term use under medical supervision, Tofajak provides targeted relief with minimal systemic exposure, making it an effective non-steroidal option for chronic inflammatory dermatoses.